You are here: Industry Insights > Thermo Fisher

News List

Thermo Fisher acquires PPD, a CRO, in $17.4 billion deal expresspharma
April 19, 2021
Thermo Fisher Scientific said it would acquire contract researcher PPD for $17.4 billion as it looks to add more muscle to its pharmaceutical services business.
Thermo Fisher Acquires PPD for $17.4B contractpharma
April 16, 2021
Thermo Fisher Scientific has acquired clinical research services provider PPD for $17.4 billion.
Thermo Fisher Scientific Completes Mesa Biotech Acquisition contractpharma
March 02, 2021
Thermo Fisher Scientific Inc. has completed its acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company.
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector prnasia
February 24, 2021
WuXi Diagnostic Investment (Cayman) Limited announced that it has completed US$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc., Shiyu Capital, ABC International Holdings Limited, Sunland Capital and ...
FDA Grants Emergency Use Authorization for COVID-19, Flu A, Flu B Combo Kit americanpharmaceuticalreview
February 19, 2021
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit from Thermo Fisher Scientific.
Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China contractpharma
February 09, 2021
Thermo Fisher Scientific has signed an agreement with cell therapy company JW Therapeutics to ensure non-exclusive commercial access to Thermo Fisher's Gibco CTS Dynabeads CD3/CD28.
Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program americanpharmaceuticalreview
January 21, 2021
Thermo Fisher Scientific has announced an extension of its SARS-CoV-2 GlobalAccess Sequencing Program to provide additional units of the Ion Torrent Genexus System and Ion GeneStudio S5 Series sequencers at a subsidized price to further support global ...
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities contractpharma
December 18, 2020
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.
Thermo Fisher, BATL Partner to Advance Biopharma Lab Analysis contractpharma
November 06, 2020
Aims to deliver analytical solutions and training programs to streamline analysis of next-gen biotherapeutics.
Thermo Fisher, Symphogen Extend Development Pact contractpharma
October 30, 2020
Thermo Fisher Scientific and Symphogen, an affiliate of Servier, have extended a strategic collaboration to deliver innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance ...

Previous page 1 2 3 4 5 6 7 Next page